NCT05599243View on ClinicalTrials.gov

Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

August 11, 2023

Study Completion Date

August 11, 2023

Conditions
Male Androgenetic Alopecia
Interventions
DRUG

Dutasteride

The application will be made locally (spray for topical application on the scalp) Application: 1 mL (6 sprays) once a day. Each 1mL of formulation has approximately 1.5mg of Dutasteride (more precisely it would be 1.4835mg when considering density).

OTHER

Placebo

Vehicle excipient

Trial Locations (1)

28034

Hospital Ramón y Cajal, Madrid

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER